- 收听数
- 0
- 性别
- 保密
- 听众数
- 4
- 最后登录
- 2021-7-19
- QQ
 - UID
- 4465
- 阅读权限
- 10
- 帖子
- 615
- 精华
- 0
- 在线时间
- 197 小时
- 注册时间
- 2013-6-14

- 科研币
- 0
- 速递币
- 99
- 娱乐币
- 150
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
10速递币
题名 | MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. | 链接 | http://www.ncbi.nlm.nih.gov/pubmed/?term=Oral+and+vaginal+preparations+of+tenofovir+as+pre-exposure+prophylaxis+(PrEP)+for+human+immunodeficiency+virus+(HIV)+infection+have+demonstrated+variable+efficacy+in+men+and+women+prompting+assessment+of+variation+in+drug+concentration+as+an+explanation.+Knowledge+of+tenofovir+concentration+and+its+active+form%2C+tenofovir+diphosphate%2C+at+the+putative+vaginal+and+rectal+site+of+action+and+its+relationship+to+concentrations+at+multiple+other+anatomic+locations+may+provide+key+information+for+both+interpreting+PrEP+study+outcomes+and+planning+future+PrEP+drug+development. |
|
|